✦ LIBER ✦

Predictors and impact of non-adherence in adults with attention-deficit/hyperactivity disorder receiving OROS methylphenidate: results from a randomized, placebo-controlled trial

✍ Scribed by J J Sandra Kooij, Michael Rösler, Alexandra Philipsen, Sandra Wächter…

Book ID: 120680743
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 209 KB
Volume: 13
Category: Article
ISSN: 1471-244X
DOI: 10.1186/1471-244X-13-36

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Randomized, Placebo-Controlled Trial o

A Randomized, Placebo-Controlled Trial of OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder

✍ Joseph Biederman; Eric Mick; Craig Surman; Robert Doyle; Paul Hammerness; Theres 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 283 KB

A Randomized, Placebo-Controlled Trial o

A Randomized, Placebo-Controlled Trial of Three Fixed Dosages of Prolonged-Release OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder

✍ Rossella Medori; J. Antoni Ramos-Quiroga; Miguel Casas; J.J.S. Kooij; Asko Nieme 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Methylphenidate Hydrochloride Modified-R

Methylphenidate Hydrochloride Modified-Release in Adults with Attention Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Trial

✍ Huss, Michael; Ginsberg, Ylva; Tvedten, Torbjorn; Arngrim, Torben; Philipsen, Al 📂 Article 📅 2013 🏛 Springer Healthcare Communications 🌐 English ⚖ 871 KB

Efficacy of reboxetine in adults with at

Efficacy of reboxetine in adults with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled clinical trial

✍ Forough Riahi; Mehdi Tehrani-Doost; Zahra Shahrivar; Javad Alaghband-Rad 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

## Abstract ## Objective The main aim of this study is to evaluate the efficacy of reboxetine, a specific noradrenergic reuptake inhibitor, in adults with attention‐deficit/hyperactivity disorder (ADHD). ## Methods In a double blind placebo‐controlled clinical trial, the efficacy of 8 mg/day of

A controlled trial of methylphenidate in

A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders

✍ Pieter J. Carpentier; Cor A. J. De Jong; Boukje A. G. Dijkstra; Cor A. G. Verbru 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Methylphenidate for attention deficit hy

Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial

✍ Konstenius, Maija; Jayaram-Lindström, Nitya; Guterstam, Joar; Beck, Olof; Philip 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 781 KB